Not logged in.png)
Share.png)
SaveShare Save A phase I/IIa first-in-human clinical trial evaluating MDX2001, a multi-specific antibody in patients with advanced solid tumor malignancies
Minchom, A. R.; Culm, K.; Garmey, E.; Makris, L.; Johnson, M. L.; Sommerhalder, D.; Garralda, E.; Henry, J.; Yang, M.; Mei, L.; Cotreau, M. M.; Goenaga, A-L.; Burzyn, D.; Yang, Z-Y.; Wei, R.; Chhaljani, V.; Mascola, J.; Nabel, G.; Dumbrava, E. E. Share Save Share Save Share Save Share Save ASCO/CAP human epidermal growth factor receptor-2 (HER2) in situ hybridization (ISH) categories evaluated by quantitative HER2 protein diagnostic methodologies: A comparative analysisBuscaglia, B.; Turner, B.; Goda, H.; Huang, W.; Leitzel, K.; Natori, T.; Nakano, Y.; Okada, H.; Sperinde, J.; Ali, S.; Vasekar, M.; D'Aguiar, M.; McMahon, L.; Henry, J.; Lipton, A.; Hicks, D. Share Save Share Save Share Save Share Save Share Save Retinoblastoma protein in human breast carcinoma. Immunohistochemical study using a new monoclonal antibody effective on routinely processed tissuesAnderson, JJ; Tiniakos, DG; McIntosh, GG; Autzen, P; Henry, JA; Thomas, MD; Reed, J; Horne, GM; Lennard, TWJ; Angus, B; Horne, CHW Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
